Valuation
- Market cap
- 1,675,891,000
- Revenue TTM
- $883,370,000
- Net income TTM
- $78,340,000
- PE ratio
- 10.20
- Forward PE
- 9.36
- Profit margin
- 8.87%
- Debt to equity
- 0.50
Trading
- Volume
- 309,500
- Avg volume
- 393,586
- Day's range
- $71.73 – $73.27
- Shares out
- 22,970,000
- Stochastic %K
- 7%
- Beta
- 0.50
- Analysts
- Strong Sell
- Price target
- $102.70
Company profile
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The comp...
Show more
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 218 634 3500
- Website
- https://www.anipharmaceuticals.com
- Address
- 210 Main Street West, Baudette, United States
Latest news
No headlines yet.
